ExodusPoint Capital Management, LP
Position in ANIP — Ani Pharmaceuticals Inc
CIK 1736225
NEW YORK, NY
Position in ANIP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,718,329
+$2,475,352 QoQ
Shares Held
32,838
+966.9% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#96
of 303 holders
Holding Since
Jun 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $55,176,557 across 18 Drug Manufacturers - Specialty & Generic names. ANIP ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
150,033 | $16,644,661 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
446,179 | $10,980,465 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
744,917 | $7,449,170 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
256,843 | $4,445,952 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
This page
|
32,838 | $2,718,329 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
33,017 | $2,111,437 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
49,984 | $2,050,843 | |
| 8 | ALKS |
Alkermes plc.
|
31,684 | $1,660,241 |
All Filings in ANIP
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,718,329 | 32,838 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $242,977 | 3,078 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $1,282,423 | 19,654 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,615,233 | 53,999 | Shares | Sole | 2025-05-14 | |
| 2021-09-30 | $208,242 | 6,345 | Shares | Sole | 2021-11-15 | |
| 2020-06-30 | $207,590 | 6,419 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||